What does CUSIP 88322Q108 represent in this 13F holders report?

CUSIP 88322Q108 is the security identifier for TGTX - TG THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held TGTX - TG THERAPEUTICS, INC. - Common Stock in Q1 2018?

120 institutional investors reported TGTX - TG THERAPEUTICS, INC. - Common Stock for Q1 2018. Use the holders table for investor-level position and value details.

TG THERAPEUTICS, INC. - Common Stock (TGTX)

CUSIP: 88322Q108

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock
Shares outstanding: 159,699,810
Total 13F shares: 38,595,106
Share change: +2,866,986
Total reported value: $548,041,984
Put/Call ratio: 53%
Price per share: $14.20
Number of holders: 120
Value change: +$48,773,765
Number of buys: 68
Number of sells: 45

Quarterly Holders Quick Answers

What is CUSIP 88322Q108?
CUSIP 88322Q108 identifies TGTX - TG THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 88322Q108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TGTX - TG THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	3.1%	4,951,213	$40,600,000	—	31 Dec 2017	13F
BRIDGER MANAGEMENT, LLC	13F	Company	2.7%	4,391,634	$36,011,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	2.1%	3,414,999	$28,003,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	2.1%	3,411,666	$27,975,000	—	31 Dec 2017	13F
Avoro Capital Advisors LLC	13F	Company	2.1%	3,294,463	$27,015,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	1.5%	2,457,415	$20,151,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.5%	2,425,710	$19,891,000	—	31 Dec 2017	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	0.85%	1,355,178	$11,112,000	—	31 Dec 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.67%	1,070,615	$8,779,043	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.39%	617,784	$5,066,000	—	31 Dec 2017	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.37%	585,439	$4,801,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.35%	559,553	$4,589,000	—	31 Dec 2017	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.34%	545,054	$4,469,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	462,270	$3,790,000	—	31 Dec 2017	13F
Artal Group S.A.	13F	Company	0.25%	400,000	$3,280,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.24%	385,756	$3,163,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	311,793	$2,557,000	—	31 Dec 2017	13F
University Of Notre Dame du Lac	13F	Individual	0.19%	302,761	$2,483,000	—	31 Dec 2017	13F
S.c.a. Candriam	13F	Individual	0.17%	270,000	$2,214,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.17%	266,970	$2,190,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.15%	245,855	$2,016,000	—	31 Dec 2017	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.13%	211,595	$1,735,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.11%	179,577	$1,472,000	—	31 Dec 2017	13F
Hikari Power Ltd	13F	Company	0.1%	160,000	$1,312,000	—	31 Dec 2017	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.09%	151,387	$1,240,000	—	31 Dec 2017	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.09%	138,384	$1,135,000	—	31 Dec 2017	13F
Allianz Asset Management GmbH	13F	Company	0.09%	137,980	$1,131,000	—	31 Dec 2017	13F
GROUP ONE TRADING LLC	13F	Company	0.08%	133,393	$1,094,000	—	31 Dec 2017	13F
CITIGROUP INC	13F	Company	0.08%	129,251	$1,060,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.08%	123,010	$1,009,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	117,990	$965,000	—	31 Dec 2017	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.07%	106,400	$872,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	104,246	$855,000	—	31 Dec 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.06%	102,853	$843,000	—	31 Dec 2017	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.06%	99,365	$815,000	—	31 Dec 2017	13F
GAM Holding AG	13F	Company	0.06%	98,600	$809,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.06%	95,704	$785,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.06%	89,424	$733,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.06%	89,300	$732,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.06%	88,736	$728,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.06%	88,271	$724,000	—	31 Dec 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	80,941	$664,000	—	31 Dec 2017	13F
UBS Group AG	13F	Company	0.05%	75,094	$616,000	—	31 Dec 2017	13F
STONERIDGE INVESTMENT PARTNERS LLC	13F	Company	0.05%	71,998	$590,000	—	31 Dec 2017	13F
Trexquant Investment LP	13F	Company	0.04%	67,243	$551,000	—	31 Dec 2017	13F
UNITED CAPITAL FINANCIAL ADVISORS, LLC	13F	Company	0.04%	66,885	$548,000	—	31 Dec 2017	13F
CREDIT SUISSE AG/	13F	Company	0.04%	66,860	$548,000	—	31 Dec 2017	13F
DUPONT CAPITAL MANAGEMENT CORP	13F	Company	0.04%	64,957	$533,000	—	31 Dec 2017	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.04%	61,092	$501,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	59,940	$492,000	—	31 Dec 2017	13F

Institutional Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2018

As of 31 Mar 2018, TG THERAPEUTICS, INC. - Common Stock (TGTX) was held by 120 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,595,106 shares. The largest 10 holders included venBio Select Advisor LLC, FMR LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, BRIDGER MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and COLUMBUS CIRCLE INVESTORS. This page lists 120 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

104

Q1 2018 holders

120

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.